New Drug for Type 2 Diabetes Coming Soon
Novo Nordisk has submitted a new drug application to the FDA in the U.S., for the approval of liraglutide, a once-daily human GLP-1 analogue, for the treatment of people with type 2 diabetes.
Diabetes Pharmacist Blog : Focus Express Mail Pharmacy : Insulin Pumps, Diabetes Supplies and Information
Published By
Focus Express Mail Pharmacy Inc.
Information & education about diabetes & related subjects
Focus Express Mail Pharmacy, is "AMERICA'S BEST KEPT SECRET" for Diabetes Medications and Supplies. At Focus, we strive toMore...
Search This Site
Enter keywords:
Recent Updates
- Does Arsenic Lead to Diabetes or Do People with Diabetes Have More Arsenic?
- Dietary Vitamin K May Slow Insulin Resistance
- Obesity and Diabetes Rates Increase Dramatically in Survey of States
- Broccoli May Offer Vascular Protection to People with Diabetes
- Gallstones Caused by Insulin Resistance in People with Diabetes
- Diabetes Medications May Control Alzheimer's
- Diabetes Dictionary, A Great Idea
- Diagnosis of Diabetes Obtained Thru Eye Examination
- New Diabetes Management System Coming
- Philadelphia Business Journal Profiles Focus Pharmacy CEO Joel Shpigel
Links